Sparrow Health System, part of University of Michigan Health, experts release findings in a study of a cancer drug for patients with genetic mutations.

Michigan Medicine has developed a new technique that provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

University of Michigan Rogel Cancer Center researchers are unraveling its nuances, advancing enabling technologies, advocating for patients and figuring out how to ethically integrate this technology into clinical care.

Nafisa (Pearring Lab) successfully defended her thesis.

Read a new publication from the Pearring Lab.

New Publication by Soubhagyalaxmi Jema and Ajit Joglekar

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma published in The Lancet Oncology.

American Association for Anatomy Newsletter Member Spotlight featuring Michael Hortsch

New publication from Pedro Lowenstein and Maria Castro's labs

A Michigan Medicine expert describes immunotherapy as “the future of cancer treatment” for those who qualify.

Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 

Cancer survivors who received treatment at the University of Michigan Health Rogel Cancer Center and infusion nurses demystify the experience by providing 10 helpful things to know ahead of time.

Developing Future Biologists (DFB) is recruiting new instructors

Connect with the Department of Cell and Developmental Biology on LinkedIn